Agomab Therapeutics

Agomab Therapeutics is a biotechnology company developing therapies that aim to preserve and restore organ function in fibrotic diseases. The company focuses on growth factor pathways to repair tissue and address conditions such as fibrostenosing Crohn’s disease.

With a pipeline targeting fibrosis and inflammatory disorders, Agomab seeks to deliver transformative treatments for patients with high unmet medical needs.